Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exclusive Enteral Nutrition in Ileocaecal Crohn's Disease
NCT04921033Phase 3Recruiting
- Sponsor
- Düzce University
- Start
- Mar 2021
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Düzce University. Primary endpoints: Percentage of participants with mucosal healing at 12 weeks and Percentage of patients that tolerate the EEN by week 12. Started Mar 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04921033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04921033.